Department of Bioimaging and Radiological Sciences, Catholic University, Pol. A. Gemelli, L.go A. Gemelli 8, 000168 Rome, Italy.
Neuroradiology. 2012 Sep;54(9):989-95. doi: 10.1007/s00234-012-1010-3.
Pilocytic astrocytoma (PA) is classified by the World Health Organization as a grade I tumor. Magnetic resonance imaging (MRI) is the gold standard in the diagnosis and follow-up of this neoplasm, and assessment of contrast enhancement (CE) pattern is essential. The purpose of this study was to investigate CE changes of non-cerebellar PA (n-C PA) stable in size with serial MRI.
Nine hundred and twelve MRI exams of 140 children with histologically proven PA were retrospectively reviewed. Patients were chosen for study inclusion if they were off therapy, without neurofibromatosis type 1, and without dimensional changes of tumor/residual tumor. In patients with CE changes, tumor size and CE size were calculated with a cross product. Descriptive statistics were calculated for continuous variables; effects of possible factors influencing changes of contrast-enhanced areas were tested.
Of 39 n-C PA satisfying the inclusion criteria, 12 showed CE changes in terms of appearance/increase or disappearance/decrease of CE areas. Three of these 12 PA were infratentorial and nine supratentorial. There were no significant correlations between age, gender, tumor localization, tumor size, and modification of CE areas.
In our experience, n-C PA may show variable CE over time in the absence of tumor/residual tumor dimension change. We recommend that CE fluctuations alone cannot be considered an indicator of tumor progression/regression.
毛细胞型星形细胞瘤(PA)被世界卫生组织归类为一级肿瘤。磁共振成像(MRI)是诊断和随访这种肿瘤的金标准,评估对比增强(CE)模式至关重要。本研究旨在研究非小脑 PA(n-C PA)的 CE 变化,这些肿瘤的大小在连续 MRI 上保持稳定。
回顾性分析了 140 例经组织学证实的 PA 患儿的 912 次 MRI 检查。选择符合研究纳入标准的患者为:已停药、无神经纤维瘤病 1 型、肿瘤/残留肿瘤无尺寸变化。在有 CE 变化的患者中,用交叉乘积计算肿瘤大小和 CE 大小。对连续变量进行描述性统计;测试可能影响对比增强区域变化的因素的影响。
在 39 例符合纳入标准的 n-C PA 中,有 12 例出现 CE 变化,表现为 CE 区域的外观/增加或消失/减少。其中 3 例为幕下,9 例为幕上。年龄、性别、肿瘤定位、肿瘤大小和 CE 区域的改变之间无显著相关性。
根据我们的经验,在没有肿瘤/残留肿瘤尺寸变化的情况下,n-C PA 可能会随着时间的推移出现不同的 CE。我们建议,CE 波动本身不能作为肿瘤进展/消退的指标。